Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

IL-15R stimulant

DRUG CLASS:

IL-15R stimulant

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

CD19 positive + CD20 positive	Burkitt Lymphoma	CD19 positive + CD20 positive	Burkitt Lymphoma	rituximab + FT596 Sensitive: D – Preclinical rituximab + FT596 Sensitive : D	rituximab + FT596 Sensitive: D – Preclinical rituximab + FT596 Sensitive : D
CD19 positive	Acute Lymphocytic Leukemia	CD19 positive	Acute Lymphocytic Leukemia	FT596 Sensitive: D – Preclinical FT596 Sensitive : D	FT596 Sensitive: D – Preclinical FT596 Sensitive : D
PD-L1 negative	Colon Cancer	PD-L1 negative	Colon Cancer	SAR445710 Sensitive: D – Preclinical SAR445710 Sensitive : D	SAR445710 Sensitive: D – Preclinical SAR445710 Sensitive : D
PD-L1 expression	Colon Cancer	PD-L1 expression	Colon Cancer	SAR445710 Sensitive: D – Preclinical SAR445710 Sensitive : D	SAR445710 Sensitive: D – Preclinical SAR445710 Sensitive : D